Goldenwell Biotech, Inc. (GWLL)

OTCMKTS · Delayed Price · Currency is USD

0.6500

0.00 (0.00%)

At close: Oct 30, 2026

Market Cap	64.35M -89.2%
Revenue (ttm)	55.00 -60.4%
Net Income	-282.12K
EPS	-0.00
Shares Out	99.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.6500
Previous Close	0.6500
Day's Range	0.6500 - 0.6500
52-Week Range	0.5100 - 7.0000
Beta	4.81
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Goldenwell Biotech

Goldenwell Biotech, Inc. engages in the nutraceutical and dietary supplements business. It offers JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2019

Country United States

Stock Exchange OTCMKTS

Ticker Symbol GWLL

Full Company Profile

Financial Performance

In 2025, Goldenwell Biotech's revenue was $55, a decrease of -60.43% compared to the previous year's $139. Losses were -$296,471, 125.5% more than in 2024.

Financial Statements